JOSE F RIVERA GUERRERO

Allopathic & Osteopathic Physicians|Internal Medicine CREST HILL, IL NPI 1316190028

General Payments — all program years on this page

$1,285.67

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $261.19 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $261.1912

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $138.576
Novo Nordisk AS $39.992
Acerta Pharma LLC $36.952
Lilly USA, LLC $30.671
Phadia US Inc. $15.011

By program year

Program yearAmountRecords
2018 $299.676
2019 $25.762
2020 $28.921
2021 $202.715
2022 $195.2111
2023 $272.2114
2024 $261.1912

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067580770 Phadia US Inc. $15.01 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097342410 Novo Nordisk Inc $15.02 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097731581 Novo Nordisk Inc $24.97 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104400465 AstraZeneca Pharmaceuticals LP $22.04 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104516442 AstraZeneca Pharmaceuticals LP $14.91 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111689028 Amgen Inc. $20.00 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111689030 Amgen Inc. $20.00 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111689032 Amgen Inc. $28.57 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111689034 Amgen Inc. $25.00 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111689036 Amgen Inc. $22.50 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111689038 Amgen Inc. $22.50 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135079608 Lilly USA, LLC $30.67 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.